IVP Group

Institutional Venture Partners (IVP) is a premier late-stage venture capital and growth equity firm based in Menlo Park, California. Founded in 1980, the firm has a long history of investing in high-growth technology and life science companies, with over $9 billion in committed capital. In the healthcare and life sciences sector, IVP focuses on growth-stage investments in digital health, biotechnology, and medical technology companies that demonstrate significant market potential. The firm is known for its partnership-driven approach, providing strategic guidance and extensive network access to help portfolio companies scale toward initial public offerings or significant acquisitions. Notable investments in the broader healthcare space include companies like Ginkgo Bioworks, HeartFlow, and Hims & Hers.